Testing the Omnipod 5 insulin pump in people with type 2 diabetes on dialysis
Treatments studied
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests an automated insulin delivery system (Omnipod 5) for people with type 2 diabetes who are on hemodialysis. The goal is to see if it helps control blood sugar safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have type 2 diabetes that requires more than one insulin shot per day or an insulin pump.
- You are on hemodialysis at least 3 times a week for kidney failure.
- You are comfortable wearing glucose sensors and the study insulin pump.
- You are willing to follow the study instructions and use the devices as told.
- You understand English well enough to safely take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special type of insulin delivery system (closed-loop) can help people with type 2 diabetes and chronic kidney disease. You'll wear a continuous glucose monitor and insulin pump, and researchers will track how your kidneys respond over time.
This study tests a new approach to help your body use insulin better, which may improve blood sugar control and slow down kidney disease. It is for people with advanced chronic kidney disease and type 2 diabetes who are not yet on dialysis.
This trial tests an automated insulin pump system for people with diabetes who also have advanced kidney disease. It may help manage blood sugar more easily.
This study follows people with type 1 diabetes who are using the Omnipod 5 insulin pump. The goal is to understand how well the system works in everyday life by collecting data from your pump, continuous glucose monitor, and occasional home blood tests over one year.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a new automated insulin pump system (Omnipod) that adjusts insulin doses on its own throughout the day for people with type 2 diabetes. The goal is to see if it helps keep blood sugar levels more stable while reducing the burden of manual insulin management.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.